ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.
medwireNews: Further analysis of patients with nonmetastatic castration-resistant prostate cancer (CRPC) from the SPARTAN trial has identified molecular biomarkers associated with... Read More
medwireNews: US researchers report a lower uptake of prostate-specific antigen (PSA) screening by transgender individuals than cisgender straight men. However,... Read More
The HSD3B1 1245C variant allele could be used as a biomarker to predict treatment response in different groups of men... Read More
